Key result
Zero-fluoroscopy catheter ablation successfully treats a pediatric left-sided accessory pathway with no 12-month recurrence.
Why the study?
Does zero-fluoroscopy catheter ablation using the NAVX Ensite 3D mapping system allow successful treatment of a left-sided accessory pathway in a pediatric patient?
Case Report (n=1)
No
Does zero-fluoroscopy catheter ablation using the NAVX Ensite 3D mapping system allow successful treatment of a left-sided accessory pathway in a pediatric patient?
Zero-fluoroscopy catheter ablation using 3D mapping is feasible for left-sided accessory pathways in children, avoiding ionizing radiation.
Supports feasibility of zero-fluoroscopy ablation in one pediatric case; leaves open safety, efficacy, and generalizability for larger cohorts.
Catheter ablation of cardiac arrhythmias in pediatric population is associated with the risk of ionizing radiation on the child. Due to a greater radiation sensitivity in children and a longer life expectancy newer techniques try to reduce the radiation exposure. A new technique for zero-fluoroscopy catheter ablation is described in a 9-year-old boy who had a left-sided concealed accessory pathway. The NAVX Ensite 3D mapping system permits catheter placement inside the venous system and movement inside the heart chambers without the use of X-rays. The success rate is similar to the techniques requiring X-rays.
No takes yet. Share an insight, caveat, or question.
Cismaru et al. (2017) conducted a case report in Paroxysmal supraventricular tachycardia (left-sided concealed accessory pathway) (n=1). Zero-fluoroscopy catheter ablation using NAVX Ensite 3D mapping system was evaluated on Arrhythmia recurrence at 12 months. Zero-fluoroscopy catheter ablation using a 3D mapping system successfully treated a left-sided concealed accessory pathway in a 9-year-old boy, with no arrhythmia recurrence at 12 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: